Related Experiment Video
Updated: Apr 21, 2026

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Decreased EAAT2 protein expression in the essential tremor cerebellar cortex
Michelle Lee1, Melody M Cheng2, Chi-Ying Lin3
1GH Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA. ml3445@cumc.columbia.edu.
Essential tremor may involve reduced levels of the glutamate transporter EAAT2 in the cerebellum. This decrease in excitatory amino acid transporter type 2 (EAAT2) could make brain cells more vulnerable to damage.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Essential tremor (ET) is a neurological disorder.
- Genetic links exist between ET and the Solute carrier family 1 (glial high affinity glutamate transporter), member 2 (SLC1A2) gene.
- SLC1A2 encodes excitatory amino acid transporter type 2 (EAAT2), crucial for clearing glutamate from synapses.
Purpose of the Study:
- To investigate the expression levels of glutamate transporters EAAT1 and EAAT2 in the cerebellar cortex of ET patients.
- To explore the potential role of glutamate transporter dysfunction in ET pathogenesis.
Main Methods:
- Western blotting was used to quantify EAAT1 and EAAT2 protein levels in postmortem cerebellar tissue from ET cases and controls.
- Immunohistochemistry was employed to study the cellular localization of EAAT1 and EAAT2.
Main Results:
- EAAT1 protein levels were comparable between ET cases and controls.
- EAAT2 protein levels were significantly reduced (approximately one-third) in the cerebellar cortex of ET cases compared to controls.
- EAAT2 was localized in astrocytic processes near Purkinje cells, a region implicated in ET pathology.
Conclusions:
- A significant reduction in cerebellar EAAT2 protein levels is observed in essential tremor.
- This deficit in EAAT2 may increase the susceptibility of Purkinje cells to excitotoxic damage in ET.
Related Concept Videos
Alterations in Muscle Tone lll
Parkinson Disease ll: Pathophysiology
Neural Regulation
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

